Neutropenia  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
LANDSCAPE 1011, NCT04585815 / 2020-002829-28: Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)

Active, not recruiting
1/2
34
Europe, US, RoW
Sasanlimab Prefilled syringe, Encorafenib, Binimetinib, Sasanlimab, Axitinib, SEA-TGT
Pfizer
Carcinoma, Non-Small-Cell Lung
05/23
06/24

Download Options